1.. Introduction
================

The analysis of arterial blood gas (ABG) is a very common test in emergency departments (EDs) for diagnosing, planning treatment, and disposition of patients with hypoxemia, acidosis, hypercapnia, and electrolyte abnormalities ([@b1-epj-07-1095]). Since ABG analyzers are not available in all emergency departments, sometimes it may take up to an hour before ABG results are available. Sampling arterial blood is time-consuming in some patients, and the patient must tolerate the pain associated with the use of the needle several times ([@b1-epj-07-1095]). In addition, it is considered to be an invasive measure that can lead to complications, such as hematoma, ischemia, arteriovenous fistula, and, occasionally, life-threatening infections ([@b2-epj-07-1095]--[@b4-epj-07-1095]).

ABG sampling is not always simple, and the procedure has some major limitations, including previous surgery such as cut-down and inadequate circulation in the extremities ([@b5-epj-07-1095]). One of the alternative methods for determining the metabolic status of the blood is capnometry. This method is non-invasive for measuring end-tidal CO~2~ (ETCO~2~) pressure, and, recently, it has been used as a tool for monitoring the quality of cardiopulmonary resuscitation (CPR) and determining the cause of bronchospasms ([@b6-epj-07-1095]). It has been demonstrated conclusively that, in proper ventilation/circulation cycles of the pulmonary blood, ETCO~2~ changes can indicate blood circulation and metabolic status. Several studies have shown that ETCO~2~ can indicate minute decreases in ventilation and increases in metabolism ([@b7-epj-07-1095]--[@b10-epj-07-1095]).

The literature review on ETCO~2~ indicated that there were some studies that had evaluated the importance of ETCO~2~ in diagnosing metabolic acid-base disorders in adult patients. In Barton and Wang's study, a strong correlation was observed between ETCO~2~ and PaCO~2~ in non-intubated patients who were referred to the ED ([@b7-epj-07-1095]). However, in studies of children with diabetic ketoacidosis (DKA), it has been reported that PaCO~2~ can be estimated effectively by using ETCO~2~ ([@b8-epj-07-1095]--[@b11-epj-07-1095]). Also, some studies have shown that ETCO~2~ can indicate the status of PCO~2~, especially in hemodynamically-stable patients ([@b1-epj-07-1095], [@b12-epj-07-1095]). Considering the correlations between PaCO~2~, HCO~3^−^~, and ETCO~2~ that have been identified in previous studies, it seems that measuring ETCO~2~ can be useful in predicting the presence and severity of metabolic acidosis. However, the validity and usefulness of the correlations that have been identified between ETCO~2~ and the parameters of ABG are matters of conflict in a few studies that have been conducted with adults that have metabolic disorders (1, 13, and 14). The aim of this study was to determine the correlation between ETCO~2~ and the parameters of ABG parameters, i.e., pH, HCO~3^−^~, B.E., and PaCO~2~, in adult patients in the ED of Imam Reza Hospital in Mashhad, Iran, who were likely to have metabolic acid-base disorders.

2.. Material and Methods
========================

2.1.. Design and setting of the research
----------------------------------------

This cross-sectional study was conducted during the six-month period from September 2012 through February 2013 in the ED of Imam Reza Hospital, the largest teaching/referral hospital in Mashhad in northeast Iran. The hospital is affiliated with Mashhad University of Medical Sciences, and the ED treats approximately 150,000 patients per year.

2.2.. Sample size and sampling
------------------------------

Considering the correlation between HCO~3^−^~ and ETCO~2~ as established by Fearon's study ([@b10-epj-07-1095]), the sample size was determined to be 62 patients (confidence interval = 95%, study power = 95%). A purposive sampling method was used to select the 62 patients. We used this sampling method because the selection of patients who were thought to have metabolic acid-base disorders was based on the judgment of the researcher.

2.3.. Selection criteria
------------------------

### 2.3.1.. Inclusion criteria

All adult patients who presented to the ED in need of an ABG analysis due to suspected metabolic acid-base disorders were included in the study.

### 2.3.2.. Exclusion criteria

Patients who were excluded from the study included those who had chronic obstructive pulmonary diseases, loss of consciousness, were intubated, were unable to tolerate capnography, and did not consent to participate.

2.4.. Data collection
---------------------

The variables of this study included demographic information (age, gender, and race), vital signs (blood pressure, pulse rate, respiration rate, body temperature, and oxygen saturation), the main presenting complaint, ABG parameters (bicarbonate (HCO~3^−^~)), partial pressure of carbon dioxide (PaCO~2~), pH, base excess (B.E.), end tidal CO~2~ (ETCO~2~), and final diagnosis. The patients' demographic information and vital signs were recorded to obtain baseline information. Before ABG sampling, ETCO~2~ was measured and recorded using sidestream nasal CO2 sampling cannula (Capnocheck® Sleep Capnograph/Oximeter, BCI^TM^ brand, provided by Smiths Medical, UK). ABG sampling was conducted for each patient, and the samples were sent to the Central Laboratory of the Hospital. The Laboratory's technician was not informed about the results of the ETCO~2~ tests. ABG and ETCO~2~ results were recorded.

2.5.. Research ethics
---------------------

The study was approved by the Ethics Committee of Mashhad University of Medical Sciences. Informed consent was obtained from all patients before their inclusion in the study. We did not perform any additional invasive procedures on the patients to acquire additional data. We collected the ABG variables from the routine laboratory records of our patients, and we used capnography, a non-invasive, bedside test that posed no harm to the patients.

2.6.. Statistical analyses
--------------------------

SPSS version 17.0 (SPSS, Inc., Chicago, Illinois, United States of America) was used to analyze the data. All categorical variables, such as chief complaint and final diagnosis, were expressed as numbers, percentages. Continuous variables, including ETCO~2~ and ABG variables were expressed as mean values ± the standard deviation (SD). Correlations of ETCO~2~ with ABG variables, such as B.E., PaCo~2~, HCO~3^−^~, and pH, were examined by Pearson correlation analysis. For more precise results, correlations were investigated for three subgroups of patients, i.e., those with acidemia (pH \< 7.35), those with alkalemia (pH \> 7.44), and those with diabetic ketoacidosis. A linear regression model was used to determine the correlations between ETCO~2~ and ABG parameters, such as B.E., PaCo~2~, HCO3, and pH. A p-value of more than 0.05 was required to accept the hypothesis. A multivariate linear regression analysis method was used to evaluate the influence of the other variables on ETCO~2~.

3.. Results
===========

During the six-month study period, 67 patients who met the inclusion criteria were included in the study, and three patients were excluded from the analysis. One of these three patients had a history of chronic obstructive pulmonary diseases, and the other two required airway management and intubation before ABG sampling. Thus, the results acquired from 64 patients (37 men and 27 women) were statistically analyzed. The range of the ages of the 64 patients was 15--90, and the mean age was 55.4 ± 22.7. Nausea and vomiting (24 cases) and drowsiness (19 cases) were the most common complaints of the subjects, and the other complaints in descending order were anuria (9.3%), dyspnea (7.8%), abdominal pain (6.2%), edema (4.6%), diarrhea (3.1%), and headache (1.5%). Final diagnoses were made for the patients, and they are identified as follows: renal failure (29 cases), diabetic ketoacidosis (8 cases), sepsis (7 cases), drug toxicity (7 cases), hyperglycemia (6 cases), gastrointestinal bleeding (6 cases), and gastroenteritis (1 case).

ABG samples were drawn from the radial artery. Thirty-eight patients had acidemia (pH \< 7.35) and 10 patients had alkalemia (pH \> 7.44). Among the patients, 52 had hypocapnia (PaCO~2~ \< 35) and 12 had hypercapnia (PaCO~2~ \> 45). All values of the ABG parameters followed a normal distribution ([Table 1](#t1-epj-07-1095){ref-type="table"}). Also, the average of ETCO~2~ was26.2 ± 6.1, and it had a symmetric and normal distribution.

There was a weak linear correlation between the level of ETCO~2~ and pH with Pearson's correlation coefficient of 0.368 (p = 0.003). The correlation between the ETCO~2~ level and pH in the acidemia group was (r = 0.413, p = 0.01, n = 38), and, in the alkalemia group, this correlation was (r = −0.56, p = 0.08, n = 10). The ETCO~2~ values changed with pH in patients with diabetic ketoacidosis, and there was no significant correlation (correlation coefficient = −0.185, p = 0.66). There was a strong linear correlation (0.869, p \< 0.001) between the ETCO~2~ level and HCO~3^−^~ with Pearson's correlation coefficient ([Figure 1](#f1-epj-07-1095){ref-type="fig"}). The correlation between the ETCO~2~ level and HCO~3^−^~ in the acidemia group was (r = 0.882, p \< 0.001), and it was (r = 0.933, p = 0.06) in the alkalemia group. The ETCO~2~ changes with HCO~3^−^~ in patients with diabetic ketoacidosis had a significant correlation (correlation coefficient = 0.942, p \< 0.001). A strong linear correlation was observed between ETCO~2~ level and PaCO~2~ with Pearson's correlation coefficient of 0.795 (p \< 0.001) ([Figure 2](#f2-epj-07-1095){ref-type="fig"}).

The correlation between ETCO~2~ level and PaCO~2~ in the acidemia group was (r = 0.875, p \< 0.001), and it was (r = 0.915, p = 0.08) in the alkalemia group. ETCO~2~ changes with PaCO~2~ in patients with diabetic ketoacidosis had a significant correlation (correlation coefficient = 0.950, p \< 0.001). There was a weak, linear correlation between ETCO~2~ level and B.E with Pearson's correlation coefficient of 0.346 (p = 0.006). The correlation between ETCO~2~ level and B.E. in the acidemia group was (r = 0.196, p = 0.25, n = 38), and it was (r = 0.733, p = 0.22, n = 10) in the alkalemia group. The changes in ETCO~2~ with B.E. in patients with diabetic ketoacidosis had a significant correlation (correlation coefficient = 0.726, p = 0.041).

Regression analysis was used to determine the correlation of ETCO~2~ and all related ABG parameters. Demonstrating the correlation of baseline ETCO~2~ with each of the ABG parameters as a model, we found that the correlations of ETCO~2~ with HCO~3^−^~ and PaCO~2~ were significant, while no significant correlations were observed for any of the other parameters. This showed that HCO~3^−^~ and PaCO~2~ are the significant predictors of ETCO~2~ among the ABG variables ([Table 2](#t2-epj-07-1095){ref-type="table"}).

4.. Discussion
==============

This study was conducted with the assumption that there might be a significant correlation between ETCO~2~ and ABG parameters. Determining such a correlation we allow us to use the ETCO~2~ level instead of arterial blood sampling. The results did, in fact, show that there was a significant correlation between all ABG parameters and ETCO~2~ in all 64 patients (including those with normal pH, acidemia, and alkalemia). Dividing patients into two groups, identified as those having acidemia and those having alkalemia, showed that the correlation was significant for all patients with acidemia, with the only exception being the correlation between ETCO~2~ and B.E. However, for the patients with alkalemia, none of the ABG parameters had a significant correlation with the ETCO~2~ level. Therefore, as previous studies have shown, measuring ETCO~2~ is very useful in patients with acidemia. However, not all such studies have produced the same results ([@b7-epj-07-1095]--[@b11-epj-07-1095]).

In most studies of children, ETCO~2~ has been reported to have a strong linear and significant correlation with PCO2, and capnometry can be used to estimate PCO~2~ ([@b8-epj-07-1095], [@b11-epj-07-1095]). In both studies conducted on children with DKA, regarding the correlation of PCO~2~ and ETCO~2~, these two variables had a strong and significant correlation with correlation coefficients of r = 0.92 and r = 0.79 ([@b8-epj-07-1095], [@b11-epj-07-1095]). Thus, using ETCO~2~ is considered useful in estimating PCO~2~ in children with DKA. Also, in the current study, the changes in ETCO~2~ had a significant correlation with PaCO~2~ in adult patients with diabetic ketoacidosis. Thus, it seems that ETCO~2~ might be a useful estimator in patients with diabetic ketoacidosis. However, more studies on adults with diabetic ketoacidosis are required. Studies conducted on adults have been limited mostly to patients with acute dyspnea who were referred to emergency departments, and acidosis was observed in most cases. However, various results have been reported. For example, one study reported that ETCO~2~ cannot be used to estimate PaCO~2~ in patients with respiratory distress ([@b15-epj-07-1095]), while another study on patients with the average age of 60.9 found a moderate correlation between ETCO~2~ and PaCO~2~ with r = 0.407 and p \< 0.001 ([@b16-epj-07-1095]). In another study on adults who had been referred to the emergency department and diagnosed with COPD, there was a moderate correlation between PCO~2~ and ETCO~2~ ([@b17-epj-07-1095]). In our study, the correlation between ETCO~2~ and PaCO~2~ was linear and significant, which was in good agreement with the results of another study ([@b1-epj-07-1095]). However, more studies on the correlation of ETCO~2~ and PCO~2~ in adults with respiratory distress are necessary to assess confounding factors, such as respiratory rate and other diseases.

Most of the studies of the correlation between ETCO~2~ and HCO~3^−^~ have been conducted with children. In a study by Agus et al. ([@b11-epj-07-1095]) on 42 patients suspected of having DKA, the correlation between ETCO~2~ and venous HCO~3^−^~ variables was reported as r = 0.84 and p \< 0.001. Also, in other studies (24, 25) on children with DKA, correlation coefficients for ETCO~2~ and venous HCO~3^−^~ were determined to be r = 0.88 and r = 0.80. In a study by Gilhotra et al. ([@b9-epj-07-1095]) with children under 18 with DKA, a strong linear correlation was observed between ETCO~2~ and HCO~3^−^~ (r = 0.72). Like the correlation between ETCO~2~ and PCO~2~, the correlation between ETCO~2~ and HCO~3^−^~ in children with DKA has been demonstrated in almost all studies. In the current study, this correlation was significant in adults with DKA. However, no study has been conducted to assess the correlation between these two variables in adults. In a study by Mutlu et al. ([@b18-epj-07-1095]) on 240 adults who were referred to the emergency department with suspected metabolic disorders, a moderate correlation was observed between ETCO~2~ and HCO~3^−^~ (r = 0.50). In a study by Fearon et al. ([@b10-epj-07-1095]), a significant linear correlation was observed between ETCO~2~ and HCO~3^−^~ (r = 0.80, p \< 0.0001), and we found the same correlation as well. Different measuring methods, various sample sizes, and concurrent diseases can describe the differences in the correlation coefficient of the current study, Fearon's study, and Multu's study. In a study by Joshua ([@b19-epj-07-1095]) on children with gastroenteritis, r = 0.80 was reported on the correlation between ETCO~2~ and blood HCO~3^−^~ level, and it is reported that ETCO~2~ can be used to estimate HCO~3^−^~ in children with diarrhea and vomiting. It seems that using ETCO~2~ to estimate HCO~3^−^~ has been demonstrated in most studies so it can be appropriate to use ETCO~2~ as an indicator of HCO3 especially in emergency situations.

Only one study has been conducted to determine the correlation between ETCO~2~ and pH, i.e., a study by Garcia et al. ([@b8-epj-07-1095]). A correlation coefficient of r = 0.88 with a significance level of p \< 0.001 was reported for the correlation between ETCO~2~ and pH. In the current study, this correlation was not strong, but it was moderate and linear in patients referred to the emergency department in general and in patients with acidemia and alkalemia. However, one cannot form a definite conclusion based on the two studies, and more research seems necessary. Although a significant correlation was observed between ETCO~2~ and some ABG parameters in the current study as in all similar studies, there have yet to be any studies to determine the possible correlation between ETCO~2~ and all ABG parameters as a unique model. Since ABG interpretation is based on all parameters, ETCO~2~ can be used as a substitute for ABG when there is a significant correlation with all ABG parameters. We used regression analysis in this study in an attempt to investigate the indicator power of ETCO~2~ regarding the change in each ABG variable as a model. This is a major contribution of our study. The analysis showed that among ABG parameters as a model, only HCO~3^−^~ and PaCO~2~ have a significant correlation with ETCO~2~. Thus, ETCO~2~ cannot be considered as an indicator that is correlated with all ABG variables. However, it can be an appropriate indicator to estimate HCO~3^−^~ and PaCO~2~ in critical emergency situations. In order to use ETCO~2~ as the gold standard in diagnosing metabolic disorders, its sensitivity and specificity must be determined, but that was not the purpose of this study.

Considering the expenses involved, our sample size had to be minimized, and we suggest larger sample sizes in future studies. Since most patients referred to the emergency department during the study were diagnosed with chronic renal disease and diabetic ketoacidosis, it was not possible to precisely estimate ETCO~2~ function in more diseases with various acid-base disturbances. Thus, it is recommended that future studies divide patients into four groups, i.e., acidosis, alkalosis, respiratory, and metabolic, which should provide a better comparison of ETCO~2~ application between the groups. Since there were no healthy individuals in the groups, it was not possible to estimate the correlation between ETCO~2~ level and ABG parameters in healthy individuals and compare that with acid-base disturbances. Therefore, it is recommended that future studies include a control group of healthy individuals.

5.. Conclusions
===============

The findings of this study indicate that ETCO~2~ may not be useful as an indicator in estimating all ABG variables; however, as a fast, inexpensive, and non-invasive test, it can be an appropriate indicator to estimate HCO~3^−^~ and PaCO~2~ in critical, emergency situations. Further studies are needed to determine whether capnography can be used to accelerate the recognition of metabolic disturbances in the emergency department and decrease the time required to identify the appropriate therapy in critical situations.
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###### 

Mean ABG variables and ETCO~2~ with standard deviations and ranges

  Variable               Mean ± SD     Range
  ---------------------- ------------- ------------
  PH                     7.33 ± 0.08   7.15--7.5
  HCO~3^−^~ (mEq/L)      18.9 ± 6.2    7.10--38.8
  PaCO~2~ (mmHg)         33.1 ± 9.6    10--78.9
  O~2~ Saturation (%)    82.7 ± 12.8   39.8--99
  Base Excess (mmol/L)   −4.4 ± 4.6    −15--15.7
  ETCO~2~                26.2 ± 6.1    11--40

###### 

Results of linear regression displaying (β), p-values, and 95% confidence intervals for baseline ETCO~2~

  Variable          (β)     p-value   95% Confidence Interval
  ----------------- ------- --------- -------------------------
  pH                0.088   0.42      (−9.0--21.1)
  HCO~3^−^~         0.530   0.01      (0.13--0.92)
  PaCO~2~           0.353   0.04      (0.00--0.44)
  O~2~ Saturation   0.041   0.52      (−0.04--0.08)
  Base Excess       0.093   0.89      (−0.17--0.19)
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